297 related articles for article (PubMed ID: 19296235)
1. Direct renin inhibitors: ONTARGET for success?
Pasha Y; Gusbeth-Tatomir P; Covic A; Goldsmith D
Int Urol Nephrol; 2009; 41(2):341-55. PubMed ID: 19296235
[TBL] [Abstract][Full Text] [Related]
2. Renal and cardio-protective effects of direct renin inhibition: a systematic literature review.
Lambers Heerspink HJ; Perkovic V; de Zeeuw D
J Hypertens; 2009 Dec; 27(12):2321-31. PubMed ID: 19727007
[TBL] [Abstract][Full Text] [Related]
3. Have the renin-angiotensin-aldosterone system perturbations in cardiovascular disease been exhausted?
Mansur SJ; Hage FG; Oparil S
Curr Cardiol Rep; 2010 Nov; 12(6):450-63. PubMed ID: 20827517
[TBL] [Abstract][Full Text] [Related]
4. [Debate concerning the optimal blockage of the renin-angiotensin system].
Choukroun G
Nephrol Ther; 2010 Jan; 6 Spec No 1():H1-9. PubMed ID: 20129454
[No Abstract] [Full Text] [Related]
5. Updates on the treatment of essential hypertension: a summary of AHRQ's comparative effectiveness review of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and direct renin inhibitors.
Powers B; Greene L; Balfe LM
J Manag Care Pharm; 2011 Oct; 17(8 Suppl):S1-14. PubMed ID: 22088101
[TBL] [Abstract][Full Text] [Related]
6. Development of inhibitors of the aspartyl protease renin for the treatment of hypertension.
Scott BB; McGeehan GM; Harrison RK
Curr Protein Pept Sci; 2006 Jun; 7(3):241-54. PubMed ID: 16787263
[TBL] [Abstract][Full Text] [Related]
7. The evolution of renin-angiotensin blockade: angiotensin-converting enzyme inhibitors as the starting point.
Sica DA
Curr Hypertens Rep; 2010 Apr; 12(2):67-73. PubMed ID: 20424943
[TBL] [Abstract][Full Text] [Related]
8. Renin inhibitors: optimal strategy for renal protection.
Schmieder RE
Curr Hypertens Rep; 2007 Nov; 9(5):415-21. PubMed ID: 18177590
[TBL] [Abstract][Full Text] [Related]
9. Renin-angiotensin-aldosterone system inhibition: overview of the therapeutic use of angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, mineralocorticoid receptor antagonists, and direct renin inhibitors.
Mercier K; Smith H; Biederman J
Prim Care; 2014 Dec; 41(4):765-78. PubMed ID: 25439533
[TBL] [Abstract][Full Text] [Related]
10. Renin-angiotensin system blocking drugs.
Robles NR; Cerezo I; Hernandez-Gallego R
J Cardiovasc Pharmacol Ther; 2014 Jan; 19(1):14-33. PubMed ID: 24038019
[TBL] [Abstract][Full Text] [Related]
11. [Renin inhibition and the kidney].
Ecder T
Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():28-31. PubMed ID: 20019474
[TBL] [Abstract][Full Text] [Related]
12. [The future of renin inhibition].
Uresin AY; Baran E
Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():32-8. PubMed ID: 20019475
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the renin-angiotensin-aldosterone system: is there room for dual blockade in the cardiorenal continuum?
Volpe M; Danser AH; Menard J; Waeber B; Mueller DN; Maggioni AP; Ruilope LM
J Hypertens; 2012 Apr; 30(4):647-54. PubMed ID: 22278139
[TBL] [Abstract][Full Text] [Related]
14. [Overview of the RAAS in renal damage and hypertension].
Yamamoto T; Nishiyama A
Nihon Jinzo Gakkai Shi; 2010; 52(2):87-91. PubMed ID: 20415226
[No Abstract] [Full Text] [Related]
15. Renin-angiotensin-aldosterone system blockade and renal protection: angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers?
Ruilope LM
Acta Diabetol; 2005 Apr; 42 Suppl 1():S33-41. PubMed ID: 15868118
[TBL] [Abstract][Full Text] [Related]
16. Novel drugs targeting hypertension: renin inhibitors.
Danser AH
J Cardiovasc Pharmacol; 2007 Aug; 50(2):105-11. PubMed ID: 17703126
[TBL] [Abstract][Full Text] [Related]
17. [The renin-angiotensin system in hypertension and in cardiovascular and renal diseases: highlights of the World Congress of Nephrology 2009]].
Romet M
Nephrol Ther; 2010 Jan; 6 Spec No 1():H10-3. PubMed ID: 20129455
[No Abstract] [Full Text] [Related]
18. Angiotensin receptor blockers and cardiovascular protection: are we ONTARGET?
Ram CV; Deedwania PC
Am J Cardiol; 2008 Nov; 102(9):1281-3. PubMed ID: 18940307
[No Abstract] [Full Text] [Related]
19. ONTARGET: How much RAS inhibition is enough?
Weder AB
Curr Hypertens Rep; 2009 Feb; 11(1):7-9. PubMed ID: 19146793
[No Abstract] [Full Text] [Related]
20. Role of angiotensin II in cardiovascular disease therapeutic implications of more than a century of research.
Ferrario CM
J Renin Angiotensin Aldosterone Syst; 2006 Mar; 7(1):3-14. PubMed ID: 17083068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
